The two FIGO systems for normal and abnormal uterine bleeding symptoms and classification of causes of abnormal uterine bleeding in the reproductive years: 2018 revisions
- PMID: 30198563
- DOI: 10.1002/ijgo.12666
The two FIGO systems for normal and abnormal uterine bleeding symptoms and classification of causes of abnormal uterine bleeding in the reproductive years: 2018 revisions
Erratum in
-
Corrigendum to "The two FIGO systems for normal and abnormal uterine bleeding symptoms and classification of causes of abnormal uterine bleeding in the reproductive years: 2018 revisions" [Int J Gynecol Obstet 143(2018) 393-408.].Int J Gynaecol Obstet. 2019 Feb;144(2):237. doi: 10.1002/ijgo.12709. Epub 2018 Nov 27. Int J Gynaecol Obstet. 2019. PMID: 30609040 No abstract available.
Abstract
Background: The International Federation of Gynecology and Obstetrics (FIGO) systems for nomenclature of symptoms of normal and abnormal uterine bleeding (AUB) in the reproductive years (FIGO AUB System 1) and for classification of causes of AUB (FIGO AUB System 2; PALM-COEIN) were first published together in 2011. The purpose was to harmonize the definitions of normal and abnormal bleeding symptoms and to classify and subclassify underlying potential causes of AUB in the reproductive years to facilitate research, education, and clinical care. The systems were designed to be flexible and to be periodically reviewed and modified as appropriate.
Objectives: To review, clarify, and, where appropriate, revise the previously published systems.
Methodology and outcome: To a large extent, the process has been an iterative one involving the FIGO Menstrual Disorders Committee, as well as a number of invited contributions from epidemiologists, gynecologists, and other experts in the field from around the world between 2012 and 2017. Face-to-face meetings have been held in Rome, Vancouver, and Singapore, and have been augmented by a number of teleconferences and other communications designed to evaluate various aspects of the systems. Where substantial change was considered, anonymous voting, in some instances using a modified RAND Delphi technique, was utilized.
Keywords: Abnormal uterine bleeding; Adenomyosis; Anovulatory bleeding; Arteriovenous malformation; Coagulopathy; Endometrial hyperplasia; Endometrial polyp; FIGO; Heavy menstrual bleeding; Heavy uterine bleeding; Intermenstrual bleeding; Irregular menstrual bleeding; Irregular uterine bleeding; Isthmocele; Leiomyoma; Menorrhagia; Metrorrhagia; PALM-COEIN.
© 2018 International Federation of Gynecology and Obstetrics.
Comment in
-
Our path from abnormal uterine bleeding and iron deficiency to impaired fetal development: A long and winding road.Int J Gynaecol Obstet. 2023 Aug;162 Suppl 2:3-6. doi: 10.1002/ijgo.14942. Int J Gynaecol Obstet. 2023. PMID: 37538012 No abstract available.
Similar articles
-
National survey of abnormal uterine bleeding according to the FIGO classification in Japan.J Obstet Gynaecol Res. 2023 Jan;49(1):321-330. doi: 10.1111/jog.15464. Epub 2022 Oct 18. J Obstet Gynaecol Res. 2023. PMID: 36258286
-
Contemporary evaluation of women and girls with abnormal uterine bleeding: FIGO Systems 1 and 2.Int J Gynaecol Obstet. 2023 Aug;162 Suppl 2(Suppl 2):29-42. doi: 10.1002/ijgo.14946. Int J Gynaecol Obstet. 2023. PMID: 37538019 Free PMC article.
-
PALM-COEIN Nomenclature for Abnormal Uterine Bleeding.J Midwifery Womens Health. 2016 May;61(3):376-9. doi: 10.1111/jmwh.12440. Epub 2016 Mar 11. J Midwifery Womens Health. 2016. PMID: 26969858
-
Practical aspects of the two FIGO systems for management of abnormal uterine bleeding in the reproductive years.Best Pract Res Clin Obstet Gynaecol. 2017 Apr;40:3-22. doi: 10.1016/j.bpobgyn.2016.09.011. Epub 2016 Oct 1. Best Pract Res Clin Obstet Gynaecol. 2017. PMID: 27836285 Review.
-
Classification of menstrual bleeding disorders.Rev Endocr Metab Disord. 2012 Dec;13(4):225-34. doi: 10.1007/s11154-012-9220-x. Rev Endocr Metab Disord. 2012. PMID: 22851041 Review.
Cited by
-
Interventions commonly available during pandemics for heavy menstrual bleeding: an overview of Cochrane Reviews.Cochrane Database Syst Rev. 2020 Jul 23;7(7):CD013651. doi: 10.1002/14651858.CD013651.pub2. Cochrane Database Syst Rev. 2020. PMID: 32700364 Free PMC article.
-
Predictors of response for elagolix with add-back therapy in women with heavy menstrual bleeding associated with uterine fibroids.Am J Obstet Gynecol. 2021 Jan;224(1):72.e1-72.e50. doi: 10.1016/j.ajog.2020.07.032. Epub 2020 Jul 20. Am J Obstet Gynecol. 2021. PMID: 32702363 Free PMC article.
-
Clinical Application of Digital 3D Reconstruction and 3D Printing Technology in Endometrial Cancer (EC) Surgery.Comput Math Methods Med. 2022 Sep 14;2022:9180216. doi: 10.1155/2022/9180216. eCollection 2022. Comput Math Methods Med. 2022. Retraction in: Comput Math Methods Med. 2023 Dec 13;2023:9878272. doi: 10.1155/2023/9878272. PMID: 36158121 Free PMC article. Retracted.
-
COVID-19 and abnormal uterine bleeding: potential associations and mechanisms.Clin Sci (Lond). 2024 Feb 21;138(4):153-171. doi: 10.1042/CS20220280. Clin Sci (Lond). 2024. PMID: 38372528 Free PMC article. Review.
-
Pipelle Endometrial Biopsy for Abnormal Uterine Bleeding in Daily Clinical Practice: Why the Approach to Patients Should Be Personalized?J Pers Med. 2021 Sep 28;11(10):970. doi: 10.3390/jpm11100970. J Pers Med. 2021. PMID: 34683110 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical